IRCT20181208041882N13
Completed
Phase 3
Evaluation of N-acetylcysteine efficacy compared to placebo in the treatment of diarrhea caused by rotavirus in children: a randomized, double-blind clinical trial.
Yazd University of Medical Sciences0 sites64 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Diarrhea caused by rotavirus.
- Sponsor
- Yazd University of Medical Sciences
- Enrollment
- 64
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Rotavirus infection has been confirmed in patient.
- •The age range of the patient is between 6 months and 5 years
- •Absence of genetic or chronic diseases in patients
- •Insensitivity to N\-acetylcysteine
- •Do not receive ibuprofen
Exclusion Criteria
- •Patients who refer after 48 hours from the onset of diarrhea.
- •Patients who receive ibuprofen.
- •Hypersensitivity to N\-acetylcysteine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The effect of acetylcysteine and bromhexine on the improvement and prevention of hospitalization in outpatients with Covid-19IRCT20220302054167N1Hamedan University of Medical Sciences225
Recruiting
Phase 3
acetylcysteine and vitamin E in transfusion dependent ß-thalassemiaTransfusion dependent beta-thalassemia.Transfusion dependent beta-thalassemiaD56.1IRCT20081207001494N3Shiraz University of Medical Sciences75
Recruiting
Phase 3
Effect of N-acetylcysteine ??and bromhexine pneumothoraxIRCT20220529055014N1Bam University of Medical Sciences50
Completed
Phase 2
Assessment of efficacy of N-Acetylecysteine plus standard quadruple therapy regimen in comparison to standard quadruple therapy regimen for H. pylori infection eradiacatioHelicobacter pylori.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT201605201155N24Vice chancellor for research of Guilan University of Medical Sciences46
Recruiting
Phase 3
Effects of N-acetylcysteine administration in the treatment of fibrocystic changes of breastBreast fibrocystic disease.Benign mammary dysplasiaIRCT20170513033941N69Kashan University of Medical Sciences74